Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque

被引:117
作者
Bonderman, D
Teml, A
Jakowitsch, J
Adlbrecht, C
Gyöngyösi, M
Sperker, W
Lass, H
Mosgoeller, W
Glogar, DH
Probst, P
Maurer, G
Nemerson, Y
Lang, IM
机构
[1] Univ Vienna, Div Cardiol, Dept Internal Med 2, A-1090 Vienna, Austria
[2] Ludwig Boltzmann Inst Cardiovasc Res, Vienna, Austria
[3] Inst Mol Oncol, Vienna, Austria
[4] CUNY Mt Sinai Sch Med, New York, NY 10029 USA
关键词
D O I
10.1182/blood.V99.8.2794
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Defined angiographically, no-reflow (NR) manifests as an acute reduction in coronary flow in the absence of epicardial vessel obstruction. One candidate protein to cause coronary NR is tissue factor (TF), which is abundant in atherosclerotic plaque and a cofactor for activated plasma coagulation factor VII. Scrapings from atherosclerotic carotid arteries contained TF activity (corresponding to 33.03 +/- 13.00 pg/cm(2) luminal plaque surface). Active TF was sedimented, indicating that TF was associated with membranes. Coronary blood was drawn from 6 patients undergoing coronary interventions with the distal protection device PercuSurge GuardWire (Traatek, Miami, FL). Fine particulate material that was recovered from coronary blood showed TF activity (corresponding to 91.1 +/- 62.16 pg/mL authentic TF). To examine the role of TF in acute coronary NR, blood was drawn via a catheter from coronary vessels in 13 patients during NR and after restoration of flow. Mean TF antigen levels were elevated during NR (194.3 +/- 142.8 pg/mL) as compared with levels after flow restoration (73.27 +/- 31.90 pg/mL P = .02). To dissect the effects of particulate material and purified TF on flow, selective intracoronary injection of atherosclerotic material or purified relipidated TF was performed in a porcine model. TF induced NR in the model, thus strengthening the concept that TF Is causal, not just a bystander to atherosclerotic plaque material. The data suggest that active TF is released from dissected coronary atherosclerotic plaque and Is one of the factors causing the NR phenomenon. Thus, blood-borne TF in the coronary circulation is a major determinant of flow. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:2794 / 2800
页数:7
相关论文
共 36 条
[21]   Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes [J].
Mallat, Z ;
Benamer, H ;
Hugel, B ;
Benessiano, J ;
Steg, PG ;
Freyssinet, JM ;
Tedgui, A .
CIRCULATION, 2000, 101 (08) :841-843
[22]   Identification of active tissue factor in human coronary atheroma [J].
Marmur, JD ;
Thiruvikraman, SV ;
Fyfe, BS ;
Guhu, A ;
Sharma, SK ;
Ambrose, JA ;
Fallon, JT ;
Nemerson, Y ;
Taubman, MB .
CIRCULATION, 1996, 94 (06) :1226-1232
[23]  
MILETICH JP, 1981, METHOD ENZYMOL, V80, P221
[24]  
NEMERSON Y, 1995, THROMB HAEMOSTASIS, V74, P180
[25]   Long-term outcome after primary angioplasty: Report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) Trial [J].
Nunn, CM ;
O'Neill, WW ;
Rothbaum, D ;
Stone, GW ;
O'Keefe, J ;
Overlie, P ;
Donohue, B ;
Grines, L ;
Browne, KF ;
Vlietstra, RE ;
Catlin, T ;
Grines, CL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) :640-646
[26]   Regulation of monocyte procoagulant activity in acute myocardial infarction:: role of tissue factor and tissue factor pathway inhibitor-1 [J].
Ott, I ;
Andrassy, M ;
Zieglgänsberger, D ;
Geith, S ;
Schömig, A ;
Neumann, FJ .
BLOOD, 2001, 97 (12) :3721-3726
[27]  
PASSAMANI E, 1985, NEW ENGL J MED, V312, P932
[28]   INCIDENCE AND TREATMENT OF NO-REFLOW AFTER PERCUTANEOUS CORONARY INTERVENTION [J].
PIANA, RN ;
PAIK, GY ;
MOSCUCCI, M ;
COHEN, DJ ;
GIBSON, CM ;
KUGELMASS, AD ;
CARROZZA, JP ;
KUNTZ, RE ;
BAIM, DS .
CIRCULATION, 1994, 89 (06) :2514-2518
[29]   Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor [J].
Rauch, U ;
Bonderman, D ;
Bohrmann, B ;
Badimon, JJ ;
Himber, J ;
Riederer, MA ;
Nemerson, Y .
BLOOD, 2000, 96 (01) :170-175
[30]   Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein:: release of a contracting factor via a novel receptor [J].
Saifeddine, M ;
Roy, SS ;
Al-Ani, B ;
Triggle, CR ;
Hollenberg, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (07) :1445-1454